Skip to main content
logo
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.169
-0.001 (-0.12%)
Sep 28, 2026, 10:22 AM EDT - Market open

SXTP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4236--
Market Cap Growth
-27.96%-27.45%-49.90%---
Enterprise Value
38814--
Last Close Price
1.172.0325.80244.80--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.391.534.3523.33--
PB Ratio
1.630.640.751.23--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.675.4511.1554.05--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.050.040.04-0.94-1.04
Net Debt / Equity Ratio
-0.34-0.77-0.82-0.41-0.92-1.03
Net Debt / EBITDA Ratio
0.100.340.330.39-13.01-17.09
Net Debt / FCF Ratio
0.100.370.560.43-22.13-28.66
Asset Turnover
0.290.250.100.060.383.18
Inventory Turnover
3.915.2511.821.361.597.36
Quick Ratio
0.991.772.340.840.010.41
Current Ratio
2.332.663.252.550.051.85
Return on Equity (ROE)
-332.85%-200.92%-181.78%---
Return on Assets (ROA)
-127.11%-87.17%-89.67%-70.95%-81.32%-35.13%
Return on Capital Employed (ROCE)
-321.50%-220.20%-236.80%-104.20%7.70%-148.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-209.59%-342.51%-268.15%-63.66%--
FCF Yield
-216.16%-325.01%-194.08%-77.77%--
Buyback Yield / Dilution
-506.60%-489.64%-585.60%---
SEC Filings: 10-K · 10-Q